The Hospital Gold Standard Catches Just 5% of Arrhythmias with Vlastimil Hrabal

<p>In this episode, your host, Jordan Burgin, is joined by Vlastimil Hrabal, CEO and Co-Founder of Kardi AI, to unpack why a 24-hour Holter monitor the hospital gold standard misses most dangerous arrhythmias, and how long-term, AI-evaluated ECG monitoring is changing detection, prevention, and the economics of cardiac care.</p><p>Key Topics</p><p>Why long-term ECG monitoring outperforms the 24-hour Holter standard</p><p>Building two AI models one to detect arrhythmias, one to strip out noise and artifacts</p><p>Earning clinician trust through MDR Class IIa certification and university-hospital studies</p><p>A three-channel commercial model: hospitals, direct-to-consumer, and employee benefits</p><p>Scaling a regulated device across Central Europe, India, the Gulf and Southeast Asia</p><p>Raising a Series A in a tougher, more data-hungry healthcare capital market</p><p>Related Insights</p><p>Why roughly half of arrhythmia patients are asymptomatic and what that means for screening</p><p>How AI can act as a “third eye” for cardiologists rather than replacing them</p><p>What sustained patient “stickiness” (four measurements a week, over years) reveals about real-world value</p><p>Localising a regulated medical device market by market pricing, partners and presence</p><p>Core Challenges</p><p>A 24-hour Holter monitor detects an arrhythmia in only ~3–5% of cases, because dangerous rhythms such as atrial fibrillation appear unpredictably and are easily missed in a single day’s snapshot while patients can wait three to six months for testing and weeks more for results.</p><p>Kardi AI’s certified, wearable long-term ECG belt lets patients measure anytime, with AI-evaluated reports returned within five minutes to both patient and physician reportedly a 10× higher detection rate, while reducing clinician workload and false positives.</p><p><br></p><p>🎧 Tune in now to hear why the future of cardiac care is continuous, AI-evaluated, and built for prevention not just diagnosis.</p><p><br></p><p>The Crux of MedTech podcast is brought to you by Cruxx, a specialist surgical robotics recruitment agency. </p><p><br></p><p>To learn more about Cruxx,<a href="https://www.thisiscruxx.com/">⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ ⁠click here.⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠</a></p><p><br></p><p>A big thank you to our sponsors on this season of the podcast; </p><p><br></p><p><a href="https://www.linkedin.com/company/the-technology-partnership/">⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠TTP plc⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠</a> With a 35-year track record, TTP excels in turning innovative ideas into market-ready solutions. Their team of 300+ experts deliver breakthrough solutions in areas ranging from endoluminal robotics and navigation systems to ultrasound imaging. Whether you&#39;re a startup or a multinational, <a href="https://www.linkedin.com/company/the-technology-partnership/">⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠TTP plc⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠</a> can accelerate your development with the latest technologies. Learn more at <a href="http://ttp.com/">⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠TTP.com⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠</a></p><p><br></p><p><br></p><p><br></p><p><br></p>